Ibrutinib and venetoclax for first-line treatment of CLL

Arnon P. Kater, Mark-David Levin, Carsten U. Niemann

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)788-789
Number of pages2
JournalNew England Journal of Medicine
Volume381
Issue number8
DOIs
Publication statusPublished - 22 Aug 2019
Externally publishedYes

Cite this